Roche investigators say Invirase does not cause cross-resistance to other protease inhibitors.
Baker
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004352:Drug Resistance, Microbial / Q000235:genetics; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use*; D009154:Mutation; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D019258:Saquinavir
D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011804:Quinolines; D019258:Saquinavir